The Precautionary Principle and Pharmaceutical Risk Management

被引:0
作者
Torbjörn Callréus
机构
[1] University of Southern Denmark,Research Unit of Clinical Pharmacology, Institute of Public Health
来源
Drug Safety | 2005年 / 28卷
关键词
Adverse Drug Reaction; Bovine Spongiform Encephalopathy; Precautionary Principle; Maastricht Treaty; Safety Surveillance;
D O I
暂无
中图分类号
学科分类号
摘要
Although it is often vigorously contested and has several different formulations, the precautionary principle has in recent decades guided environmental policy making in the face of scientific uncertainty. Originating from a criticism of traditional risk assessment, the key element of the precautionary principle is the justification for acting in the face of uncertain knowledge about risks. In the light of its growing invocation in various areas that are related to public health and recently in relation to drug safety issues, this article presents an introductory review of the main elements of the precautionary principle and some arguments conveyed by its advocates and opponents. A comparison of the characteristics of pharmaceutical risk management and environmental policy making (i.e. the setting within which the precautionary principle evolved), indicates that several important differences exist. If believed to be of relevance, in order to avoid arbitrary and unpredictable decision making, both the interpretation and possible application of the precautionary principle need to be adapted to the conditions of pharmaceutical risk management.
引用
收藏
页码:465 / 471
页数:6
相关论文
共 38 条
  • [11] Tukker A(1999)Precautionary principle stifles discovery [letter] Nature 400 398-92
  • [12] Grandjean P(2003)A compass for health: rethinking precaution and its role in science and public health Int J Epidemiol 32 489-81
  • [13] Tickner JA(2000)Risk management: science and the precautionary principle Science 288 979-803
  • [14] Antonopoulou L(2003)From general policy to legal rule: aspirations and limitations of the precautionary principle Environ Health Perspect 111 1799-20
  • [15] van Meurs MP(2003)Pondering the precautionary principle Joint Bone Spine 70 318-9
  • [16] Lefebvre S(2004)Failing the public health: rofecoxib, Merck, and the FDA N Engl J Med 351 1707-83
  • [17] Holm S(2004)Ranking and prioritization of environmental risks of pharmaceuticals in surface waters Regul Toxicol Pharmacol 39 158-86
  • [18] Harris J(2003)Quantitative methods in pharmacovigilance: focus on signal detection Drug Saf 26 159-65
  • [19] Tickner JA(1997)Principles of signal detection in pharmacovigilance Drug Saf 16 355-5
  • [20] Kriebel D(2000)Pharmacovigilance based on prescription databases Pharmacol Toxicol 86 13-undefined